Answer
Breastfeeding is contraindicated during decitabine (Dacogen) treatment and must be discontinued if treatment is required, as it is unknown whether decitabine or its metabolites enter breast milk.
Sources for this answer
- Dacogen 50 mg powder for concentrate for solution for infusion.(Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked